The NLRP4-DTX4 axis: A key suppressor of TBK1 and innate antiviral signaling

Cellular and Molecular Immunology

Volumn 9, Issue 6, 2012, Pages 431-433

  Charoenthongtrakul, Soratree ^a   Gao, Linlin ^a   Harhaj, Edward W ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GENOMIC RNA; INTERFERON; INTERFERON REGULATORY FACTOR; LEUCINE RICH REPEAT KINASE 2; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; VIRUS RNA;

ARTICLE; INNATE IMMUNITY; NONHUMAN; PROTEIN PROCESSING; RNA INTERFERENCE; UBIQUITINATION; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION;

HUMANS; INTERFERON TYPE I; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84868592540     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.49     Document Type: Article

References (12)

1. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009; 21: 317-337.
2. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-Related pathway. Science 2003; 300: 1148-1151. (Pubitemid 36583100)
3. Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS et al. The tumour suppressor CYLD is a negative regulator of RIG-Imediated antiviral response. EMBO Rep 2008; 9: 930-936.
4. Parvatiyar K, Barber GN, Harhaj EW. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem 2010; 285: 14999-15009.
5. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25: 383-392. (Pubitemid 44354221)
6. Cui J, Li Y, Zhu L, Liu D, Songyang Z, Wang HY et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol 2012; 13: 387-395.
7. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
8. Fiorentino L, Stehlik C, Oliveira V, Ariza ME, Godzik A, Reed JC. A novel PAAD-Containing protein that modulates NF-kappaB induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J Biol Chem 2002; 277: 35333-35340.
9. Gao L, Coope H, Grant S, Ma A, Ley SC, Harhaj EW. ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. J Biol Chem 2011; 286: 36592-36602.
10. Li S, Wang L, Berman M, Kong YY, Dorf ME. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 2011; 35: 426-440.
11. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430: 694-699. (Pubitemid 39061687)
12. Zhang M, Wang L, Zhao X, Zhao K, Meng H, Zhao W et al. TRAF-interacting protein (TRIP) negatively regulates IFN-Beta production and antiviral response by promoting proteasomal degradation of TANKbinding kinase 1. J Exp Med; e-Pub ahead of print 3 September 2012; doi:10.1084/jem.20120024.